A poor prognosis ER and HER2-negative, nonbasal, breast cancer subtype identified through postneoadjuvant endocrine therapy tumor profiling
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. J. Ellis, Y. Tao, J. Luo, J. Hoog, M. Watson, D. C. Allred, P. S. Bernard, T. O. Nielsen, C. M. Perou, J. Olson, Neoadjuvant Letrozole Study Group
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2250086289